{
    "code": 0,
    "data": [
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY26 Earnings Call Transcript",
            "news_id": "00c458ff-99e4-4df1-b75b-11dc69398eee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=937f9d7d-d366-4170-931d-281f106b2a1b.pdf",
            "news_date": "2026-02-03 17:03:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q3FY26 Earnings Conference Call Audio recording",
            "news_id": "fe13bcd5-e3ad-438a-b128-c30fa47ddb36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1de4697-ae87-46fd-b9d9-9b94a25b7a43.pdf",
            "news_date": "2026-01-28 21:16:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3FY26 Financial Results",
            "news_id": "f480fd25-8fec-434a-9b01-3e64666b0d78",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4106eb-8744-48f5-b7e3-2fb0d09d8755.pdf",
            "news_date": "2026-01-28 17:28:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited Financial results for the quarter and nine months ended December 31 2025",
            "news_id": "16f6db79-9412-4fc2-8b53-41c6ccfd0478",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abbfef19-482c-47db-b669-28e470f45bbe.pdf",
            "news_date": "2026-01-28 17:14:57",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2FY26 Earnings Call Transcript",
            "news_id": "f9d82f46-7183-42aa-a825-f156e4240c6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8b06a13-ec55-4396-9096-329d957bcec0.pdf",
            "news_date": "2025-11-07 16:42:06",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q2FY26 Earnings Call Audio Recording",
            "news_id": "c1a668fb-fb6d-4e8c-a054-a1eae3278c84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff0bb70b-d3e0-48ec-befc-dcb93e87e690.pdf",
            "news_date": "2025-11-03 21:24:11",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY26 Financial Results",
            "news_id": "0fa3d373-bd4f-4c71-9c42-60424bd0cdad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90359eb7-19e0-41c8-b0b9-e9c3541f0a24.pdf",
            "news_date": "2025-11-03 16:48:19",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "0e457bbc-7068-47a5-a005-849dfc0c3119",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecaea78b-a751-4978-a469-e3be6ffd5e17.pdf",
            "news_date": "2025-11-03 16:34:55",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1FY26 Earnings Call Transcript",
            "news_id": "4a690e59-53c9-47ad-9938-c11752bf4a3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=521fa767-e46d-43a5-9df7-582e1a2e5c5c.pdf",
            "news_date": "2025-08-11 17:47:17",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q1FY26 Financial Results",
            "news_id": "3b8972a6-7a58-4c8c-8591-c443bee6af87",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4e532e4-80dd-4d42-a96e-b9c7adccfe7a.pdf",
            "news_date": "2025-08-05 16:37:29",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter ended June 30 2025",
            "news_id": "8ed2eb28-1807-41ed-83db-412e75888644",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee44c072-4ee8-4c49-8667-ada77a9b3440.pdf",
            "news_date": "2025-08-05 16:25:50",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for the Earnings Call held on May 20 2025",
            "news_id": "6a90c424-ee0c-43f0-af15-69fa90a29a05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6c12ae4-ea0b-4fd5-9091-a9bf276115fb.pdf",
            "news_date": "2025-05-27 12:47:11",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings Call Audio Recording",
            "news_id": "5f21cc1e-c481-47b9-b046-a79715282e90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d13dadea-3f4f-49c3-80be-1480764dbef3.pdf",
            "news_date": "2025-05-20 22:14:25",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q4FY25",
            "news_id": "6e08b7ed-372c-479c-acbe-d59462424072",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d73d15ea-c7e4-49eb-9235-857aea24cf30.pdf",
            "news_date": "2025-05-20 17:09:36",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "8cfbe9df-3e18-4cc3-a803-1056b0eac65a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f76772f-96b3-4b3b-a419-985c7474a147.pdf",
            "news_date": "2025-02-10 18:41:03",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on Q3FY25 Financial Results",
            "news_id": "f915cd46-bbf8-404b-8338-47836bc41b2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f364bfc8-c127-40b4-a9a1-280ae7101498.pdf",
            "news_date": "2025-02-03 17:41:28",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended December 31 2024",
            "news_body": "Unaudited Financial Results for the Quarter ended December 31 2024",
            "news_id": "69cd5fc2-4a31-4acc-ad12-82e5559ad6c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cdd8edb-0ae7-45a7-adaf-adc738b16a65.pdf",
            "news_date": "2025-02-03 17:22:38",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript - November 04, 2024",
            "news_id": "065daa5e-77f7-438c-aea1-2eb6244ed3ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f92d2fd-f0bf-40fe-b4bf-297d87627c5f.pdf",
            "news_date": "2024-11-11 14:15:14",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY25 Financial Results",
            "news_id": "600eca26-eccc-4b5f-a665-16566f819f68",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33b7fb4d-ac78-47a5-9afb-926ea738b5fc.pdf",
            "news_date": "2024-11-04 17:48:43",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Unaudited financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "693b5c3d-476f-4889-8386-ee1112c3f481",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b216c63-706e-4285-84b9-7b82bde14ea2.pdf",
            "news_date": "2024-11-04 17:38:04",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on August 06, 2024",
            "news_id": "8669762b-8afc-4936-b762-e9dd46f91cc7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8f3b7a8-e203-4f66-9959-14e90a750195.pdf",
            "news_date": "2024-08-12 16:59:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q1 FY25",
            "news_id": "e71e6215-cd64-4c9b-95be-bd3565d6c472",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7325620-6f8b-4ded-a826-2765c084a968.pdf",
            "news_date": "2024-08-06 17:17:18",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Q1 FY25",
            "news_body": "Unaudited Financial Results for Q1 FY25",
            "news_id": "5d42ba17-fc9e-46df-ab52-895ee7e8bd8a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5a45625-b123-4584-aba5-b026124a87cb.pdf",
            "news_date": "2024-08-06 17:01:20",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Conference Call held on May 22, 2024",
            "news_id": "1fc10713-db14-4cb1-8950-2dc4d2ac32d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25470e59-a9c1-41ed-b6e1-31a07154e694.pdf",
            "news_date": "2024-05-29 15:15:41",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4FY24",
            "news_id": "519d5840-a8b9-4459-9281-60e01a739377",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c27b6df-3aa7-43c9-8b5e-74c3bb1c1558.pdf",
            "news_date": "2024-05-22 17:54:59",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Financial Year Ended March 31, 2024",
            "news_body": "Audited Financial Results for the Financial Year ended March 31, 2024",
            "news_id": "e07f7a4c-3348-4fa3-8c64-954a4638bcb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b23900e-1d06-4816-8fce-7568a8d59331.pdf",
            "news_date": "2024-05-22 17:41:36",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the call held on 14.02.2024",
            "news_id": "f54fc98c-634f-40b1-94cd-022d310d0f11",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f784519-61aa-4f11-b6ee-ac6358814cc2.pdf",
            "news_date": "2024-02-21 12:27:45",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earning Conference call held on 14.02.2024",
            "news_id": "0f2f3981-e85e-48d5-9eee-fd4918b40a34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e41cabc-7012-440e-8542-05556ea7b46b.pdf",
            "news_date": "2024-02-14 21:49:28",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3FY24 Financial Results",
            "news_id": "1292eda3-53d0-4346-87e0-fd2d44dd038f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b845236-a32e-46cd-a11c-fa00559b0e17.pdf",
            "news_date": "2024-02-14 16:39:54",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Board Of Directors At Its Meeting Held On February 14, 2024 Has Inter-Alia Approved The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited Financial results for the quarter and nine months ended 31.12.2023",
            "news_id": "fcd1eba0-e6ba-4d58-a209-30c207e40e82",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c062461-ac1d-4c12-814a-2da18da79346.pdf",
            "news_date": "2024-02-14 16:19:43",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter  and half year ended September  30, 2023",
            "news_id": "57d7f91f-6f69-42aa-ae94-0084636cadad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac766eae-723c-4bdc-8051-787ba2f9fd59.pdf",
            "news_date": "2023-11-06 20:57:20",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY24 Financial Results",
            "news_id": "790aad1e-9935-4d58-b151-0a14d3048527",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a90919c9-0e22-49f3-8e75-c935507dc43e.pdf",
            "news_date": "2023-11-06 16:27:56",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Unaudited financial results of the Company for the quarter and half year ended September 30, 2023",
            "news_id": "7fb0800b-f0c3-4299-8847-72c9561e7525",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=557c863e-7890-4cb5-a4cb-8ffedf0e4195.pdf",
            "news_date": "2023-11-06 16:18:27",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for Q1FY24",
            "news_id": "9f05bf42-73c5-44f3-8211-0de57feccece",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3df6e387-54da-441e-b2d3-28836c8351fd.pdf",
            "news_date": "2023-08-11 19:00:09",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter ended June 30, 2023",
            "news_id": "56ba488b-7e24-47a9-b5b9-b6d74669b7e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=637ee07b-6b74-4bc8-9ef8-1e740186c675.pdf",
            "news_date": "2023-08-07 23:10:35",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q1FY24 Financial Results",
            "news_id": "0fb6bec3-b0c8-4588-a105-10c6d4d0a357",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20d97f9a-7c32-4c82-bb6e-031381fa5439.pdf",
            "news_date": "2023-08-07 16:46:53",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2023.",
            "news_body": "Unaudited financial results of the Company for the quarter ended June 30, 2023",
            "news_id": "1ec2d2e9-7ef7-4177-beda-0c7f7c377c4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56b51db5-ae66-476e-a7cc-221b7f8a49da.pdf",
            "news_date": "2023-08-07 16:26:21",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "The Board of Directors at its meeting held on August 07, 2023 has inter-alia approved the Unaudited financial results of the Company for the quarter ended June 30, 2023.",
            "news_id": "ccf1854c-6f85-4bd3-867a-130a72ca5fa8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa524c93-5353-498e-bd97-bf551f7948b9.pdf",
            "news_date": "2023-08-07 16:18:58",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q4FY23",
            "news_id": "b403ce04-22a5-4fef-b0d4-fd445f55d23a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11224d20-b20f-4256-9061-58fc482f87b7.pdf",
            "news_date": "2023-05-25 21:29:01",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and financial year ended March 31, 2023",
            "news_id": "7de1e17a-b1e4-4822-a909-2e41aa1b2a0f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=710703c1-636c-4e6e-a93b-eff81e86a43a.pdf",
            "news_date": "2023-05-18 22:18:12",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Revised Outcome",
            "news_body": "Revised outcome-The unsigned covering letter was filed inadvertently earlier.",
            "news_id": "54c0f5e0-0909-4064-bea2-8034dc59fcb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f13af0ee-b20b-4d9b-98c7-eab8fce0c06b.pdf",
            "news_date": "2023-05-18 17:59:53",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4FY23 Financial Results",
            "news_id": "16e97786-4181-46f2-8630-17ec2385a907",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=824cdf8e-8981-46ab-9d88-e138fc5f5861.pdf",
            "news_date": "2023-05-18 17:52:40",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on May 18, 2023 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2023.<BR> <BR> The 45th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Thursday, August 31, 2023.<BR>",
            "news_id": "ae32506a-dfac-453e-b99e-dabe675a3a8a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1153f05-02a1-4f51-af6a-bb338b0a23b6.pdf",
            "news_date": "2023-05-18 17:40:55",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited Financial Results for the quarter and year ended March 31, 2023<BR>",
            "news_id": "56b5710f-292d-4ced-97c6-f65272df3730",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e0d1690-1291-4b94-bd21-d4235128d94c.pdf",
            "news_date": "2023-05-18 17:37:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on May 18, 2023 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2023.<BR> <BR> The 45th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Thursday, August 31, 2023.<BR> <BR>",
            "news_id": "b01505af-a270-4756-9ce1-8de854c71ca2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ee6c137-cca7-454e-880e-d3038891fa55.pdf",
            "news_date": "2023-05-18 17:26:07",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q3FY23",
            "news_id": "858c4368-fd53-4247-ac8d-b0e517f9f3b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd9de941-7b77-4fe6-b4ed-04c68faf369b.pdf",
            "news_date": "2023-01-31 21:57:33",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and nine months ended December 31, 2022",
            "news_id": "d5b6ab2b-75ed-4798-9bd0-99548bbacba1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=128803ed-675e-42de-8661-a7fca66f2f42.pdf",
            "news_date": "2023-01-23 22:29:19",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3FY23 Financial Results",
            "news_id": "48ea7ff7-1fcb-419e-9bf0-133c12360cf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1405d0e-3da2-454a-9024-1a71236c98eb.pdf",
            "news_date": "2023-01-23 16:37:38",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "The Board of Directors at its meeting held on January 23, 2023 has inter-alia approved the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2022.",
            "news_id": "0cf55041-7c25-4f11-aaf7-a50f50987755",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f04f5168-a49f-40cc-8d63-85ce70badcd2.pdf",
            "news_date": "2023-01-23 16:21:43",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "The Board of Directors at its meeting held on January 23, 2023 has inter-alia approved the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2022.",
            "news_id": "2783be80-6551-4ef9-95f1-01ec421cd186",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53e19a5e-2fcd-4ec8-aa2b-ce71ac1cdcd0.pdf",
            "news_date": "2023-01-23 16:12:46",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on the Proposed Acquisition of Cenexi Group",
            "news_id": "735e7349-eb75-42de-affd-8b0ae4814fbe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31782c6b-3d40-4053-9f1e-dd2d7c34f777.pdf",
            "news_date": "2022-11-29 18:01:10",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended 30Th September 2022",
            "news_body": "Related Party Transactions for the half year ended 30th September 2022",
            "news_id": "e8ff4e56-3926-460d-ad4d-06cf61787b51",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f18e68e9-e918-402c-88f3-659fa013883e.pdf",
            "news_date": "2022-11-04 17:44:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q2FY23",
            "news_id": "c258535c-436d-4b0c-9ba0-5700f6713ad4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=922c340a-a306-4b7b-bacd-a86c5b6c899e.pdf",
            "news_date": "2022-11-02 21:45:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and half year ended September 30, 2022",
            "news_id": "e68e503f-f950-4947-8c3a-28ac6509390a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7623d361-16cd-46b6-aefd-c32e22e4647a.pdf",
            "news_date": "2022-10-26 22:42:48",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY23 Financial Results",
            "news_id": "2879627c-ad2d-418f-af39-d570bef92951",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8d5a06b-5023-4642-8470-e1de0dfaf968.pdf",
            "news_date": "2022-10-26 15:59:21",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September  30, 2022",
            "news_body": "The Board of Directors at its meeting held on October 26, 2022 has inter-alia approved the Unaudited financial results of the Company for the quarter and half year ended September 30, 2022.",
            "news_id": "f8e6e718-d22c-439e-8dd2-3bef6109dc65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e3b5a1f-9049-4cb3-94d2-d66c62db6093.pdf",
            "news_date": "2022-10-26 15:46:16",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q1FY23 Financial Results",
            "news_id": "44e96062-a82f-4d01-8272-ae741e8aecb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=144ac587-0259-42d8-8200-ba44f991bb21.pdf",
            "news_date": "2022-07-20 16:13:53",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "The Board of Directors at its meeting held on July 20, 2022 has inter-alia approved the Unaudited financial results of the Company for the quarter ended June 30, 2022.",
            "news_id": "9f2d77ed-ee3d-4d00-b069-6e706a0b365e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fa95de0-f673-4492-81e3-23df7f1c2658.pdf",
            "news_date": "2022-07-20 16:02:17",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "The Board of Directors at its meeting held on July 20, 2022 has inter-alia approved the Unaudited financial results of the Company for the quarter ended June 30, 2022.",
            "news_id": "38a37999-f5d2-435a-9eee-2556e2b7a116",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7666e884-216a-4382-b0f7-6c125a747836.pdf",
            "news_date": "2022-07-20 15:59:56",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended 31St March 2022",
            "news_body": "Related Party Transactions for the Half Year Ended 31st March 2022",
            "news_id": "85e55c08-d00d-4bf2-b72e-881c57f5ea50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361e03dc-86ff-400f-9296-3242dfe3f428.pdf",
            "news_date": "2022-05-31 18:08:45",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q4FY22",
            "news_id": "025d9573-2b15-4fac-8c72-ae5cd50c8fb0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07416be0-99f7-4305-bcc0-b79589711c82.pdf",
            "news_date": "2022-05-26 18:01:06",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and year ended March 31, 2022",
            "news_id": "ae297abf-9bcb-4aa4-bc91-c5e71cc4a062",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbc45d49-e95d-45cc-bf10-d6578302a261.pdf",
            "news_date": "2022-05-19 23:31:58",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4FY22 Financial Results",
            "news_id": "7f0e2ade-d50e-4df5-92c9-63c7603daf85",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a167e0d-db79-4120-8686-c1bd05579026.pdf",
            "news_date": "2022-05-19 16:52:00",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended March 31, 2022.",
            "news_body": "Audited Financial Results for the year ended March 31, 2022.",
            "news_id": "db9b405b-ad6b-4445-91f6-c9a1e6587de2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce119c1c-9a1c-41b5-9176-667c5ce77368.pdf",
            "news_date": "2022-05-19 16:22:34",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on May 19, 2022 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2022.<BR> <BR> The 44th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Tuesday, August 30, 2022.",
            "news_id": "d434fec6-6b6c-4551-be06-2a361280ca66",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d65b14c-2f49-4770-b8f0-6a23f9ffbbc1.pdf",
            "news_date": "2022-05-19 16:08:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q3FY22",
            "news_id": "6341e99e-166c-48be-991a-f1d3255f611c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b678d18-20be-49fd-bdc8-02155d6aa3d2.pdf",
            "news_date": "2022-01-28 20:17:09",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation on the Unaudited Financial Results for the Quarter and nine months ended December 31, 2021",
            "news_id": "f6360724-6d27-4a77-8cdb-b830aeb2b74f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4abfde11-506c-405b-99d5-cc29a55d9dff.pdf",
            "news_date": "2022-01-21 15:55:02",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on January 21, 2022 has inter-alia approved the Unaudited financial results of the  Company for the quarter and nine months ended December 31, 2021",
            "news_id": "d2372692-f4ca-4515-81c4-2271596efcbd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e54ab449-93ea-4983-8a96-5845100d604d.pdf",
            "news_date": "2022-01-21 15:40:07",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q2FY22",
            "news_id": "3641537d-28ff-42ab-a54e-c2e2fb2590d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bebff46a-2a9b-491c-9b17-48218cfec14c.pdf",
            "news_date": "2021-11-03 11:31:34",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation on the Unaudited Financial Results for the Quarter and half year ended September 30, 2021",
            "news_id": "8dcf3c20-31af-4f84-876b-49a3a8e437b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f6bb216-e6c2-40bd-a839-c92d69945d1c.pdf",
            "news_date": "2021-10-22 15:47:35",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "The Board of Directors at its meeting held on October 22, 2021 has inter- alia approved the Unaudited Financial Results for the Quarter and half year ended September 30, 2021",
            "news_id": "5c63db54-b793-4259-8e25-a19491e7f99b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46e65b3e-f1a2-4322-9cd7-97e91f8116b3.pdf",
            "news_date": "2021-10-22 15:44:35",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the CEO track forum - Motilal Oswal 17th Annual Global Investor Conference to be held on September 8, 2021",
            "news_id": "fb660763-637a-42fd-846a-6f308daa2a70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fe678c2-77dd-4f17-b612-c7cbc6faa301.pdf",
            "news_date": "2021-09-07 20:27:16",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call transcript for Q1FY22",
            "news_id": "ff36acdf-6d9b-4f39-9e61-735cdc0ac0a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8eec656a-b4ce-46cf-9490-c09161cfcd36.pdf",
            "news_date": "2021-07-31 17:04:22",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation on the Unaudited Financial Results for the Quarter ended June 30, 2021",
            "news_id": "778687ac-585a-45f5-8aa8-f15fa20166f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02684a78-2997-41a0-b081-49741db48986.pdf",
            "news_date": "2021-07-21 16:36:59",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "The Board of  Directors at its meeting held on July 21, 2021 has inter- alia approved the Unaudited Financial Results of the Company for the Quarter ended June 30, 2021",
            "news_id": "4d85fdd1-5ecf-4294-826b-3b899df73288",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af54ff54-0b11-47ce-bd30-5e641b86eff5.pdf",
            "news_date": "2021-07-21 16:13:46",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript- Q4FY21",
            "news_id": "cc3d2374-cb00-4cb8-9ce0-11194ec23bd5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42607429-aaab-4cdc-95c8-5b21bcffc8c4.pdf",
            "news_date": "2021-05-21 10:01:08",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4FY21 Financial Results",
            "news_id": "cc0ce90b-5bb3-4a36-a41a-c2bae703fafd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77756a70-adf1-450d-bbbf-a067eeb45bf6.pdf",
            "news_date": "2021-05-17 17:01:29",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended March 31, 2021",
            "news_body": "The Board of Directors of Gland Pharma Limited (the 'Company') at its Meeting held today, i.e. Monday, May 17, 2021 has inter-alia considered and approved Audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2021",
            "news_id": "70e059e2-a2b0-4d7a-8d40-91c22af385a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adb8d865-be96-4e08-b661-942f98289b1a.pdf",
            "news_date": "2021-05-17 16:14:58",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}